Advisor Group’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $81K | Buy |
1,312
+14
| +1% | +$864 | ﹤0.01% | 3072 |
|
|
2019
Q3 | $94K | Sell |
1,298
-129
| -9% | -$9.34K | ﹤0.01% | 2921 |
|
|
2019
Q2 | $117K | Sell |
1,427
-338
| -19% | -$27.7K | ﹤0.01% | 2737 |
|
|
2019
Q1 | $124K | Sell |
1,765
-364
| -17% | -$25.6K | ﹤0.01% | 2667 |
|
|
2018
Q4 | $96K | Sell |
2,129
-243
| -10% | -$11K | ﹤0.01% | 2679 |
|
|
2018
Q3 | $134K | Buy |
2,372
+965
| +69% | +$54.5K | ﹤0.01% | 2523 |
|
|
2018
Q2 | $94K | Sell |
1,407
-11
| -0.8% | -$735 | ﹤0.01% | 2569 |
|
|
2018
Q1 | $83K | Sell |
1,418
-381
| -21% | -$22.3K | ﹤0.01% | 2693 |
|
|
2017
Q4 | $116K | Sell |
1,799
-66
| -4% | -$4.26K | ﹤0.01% | 2451 |
|
|
2017
Q3 | $97K | Buy |
1,865
+115
| +7% | +$5.98K | ﹤0.01% | 2427 |
|
|
2017
Q2 | $81K | Buy |
1,750
+304
| +21% | +$14.1K | ﹤0.01% | 2475 |
|
|
2017
Q1 | $71K | Buy |
1,446
+264
| +22% | +$13K | ﹤0.01% | 2421 |
|
|
2016
Q4 | $71K | Sell |
1,182
-42
| -3% | -$2.52K | ﹤0.01% | 2312 |
|
|
2016
Q3 | $82K | Buy |
1,224
+1,074
| +716% | +$72K | ﹤0.01% | 2136 |
|
|
2016
Q2 | $8K | Buy |
+150
| New | +$8K | ﹤0.01% | 3563 |
|